MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Regional subcortical volumes predict gait decline in early Parkinson’s disease

    J. Wilson, R. Lawson, B. Galna, A. Yarnall, S. Lord, R. Morris, L. Alcock, G. Duncan, T. Khoo, D. Burn, L. Rochester, J-P. Taylor (Newcastle Upon Tyne, United Kingdom)

    Objective: To predict changes in discrete gait characteristics in early Parkinson’s disease (PD) compared to healthy ageing, using subcortical brain volumes quantified in early disease.…
  • 2019 International Congress

    Comparison of Current DBS Platforms in the United States

    L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

    Objective: To compare and contrast the currently available deep brain stimulation (DBS) platforms in the United States, their technical features, capabilities and practicality of usage.…
  • 2019 International Congress

    Unilateral Leg Freezing in Moyamoya Syndrome

    R. Phattranonuthai, S. Frucht, P. Termsarasab (New York, NY, USA)

    Objective: To report unilateral leg freezing in a patient with moyamoya syndrome. Background: Angiographic moyamoya is characterized by severe bilateral distal carotid stenosis with “puff-of-smoke”…
  • 2019 International Congress

    Prolonged-release Melatonin for Sleep Disorders in Parkinson’s Disease: A Randomized trial

    JH. Ahn, M. Kim, JK. Mun, J. Youn, S. Park, W. Jang, J. Park, E. Oh, JW. Cho, JS. Kim (Seoul, Republic of Korea)

    Objective: To evaluate the efficacy of PRM in sleep disorders of patients with PD was investigated. Background: Sleep disorders are highly prevalent in patients with…
  • 2019 International Congress

    Efficacy, Safety and Tolerability of Tavapadon in Subjects With Early Stage Parkinson’s Disease

    D. Gray, R. Riesenberg, J. Werth, Y. Zhang, M. Versavel, S. Duvvuri (Boston, MA, USA)

    Objective: To evaluate the efficacy and safety of tavapadon (formerly known as PF-06649751) in subjects with early stage Parkinson’s disease. Background: Tavapadon is a potent,…
  • 2019 International Congress

    Fatal evolution of cutaneous necrosis in a patient treated with subcutaneous apomorphine infusions

    C. Marse, J. Benoit, F. Rocher, C. Giordana (Nice, France)

    Objective: Report a case of extensive cutaneous necrosis due to apomorphine treatment with fatal outcome. Background: Subcutaneous (SC) apomorphine is used as a treatment of…
  • 2019 International Congress

    A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Final study results

    T. Simuni (Chicago, IL, USA)

    Objective: The efficacy of isradipine to slow progression of disability in de novo PD participants. Background: There remains no proven therapy to slow progression of…
  • 2019 International Congress

    Effect of pill box organizers with alarm on improvement of adherence to pharmacotherapy in patients with Parkinson’s disease: a pilot study

    I. Straka, M. Minár, M. škorvánek, M. Grofik, J. Benetin, P. Valkovič (Bratislava, Slovakia)

    Objective: To find out whether pill box organizers with alarm would improve the rate of adherence in non-adherent patients with Parkinson’s disease (PD) taking three…
  • 2019 International Congress

    The role of genetic modifiers in Parkinson’s disease-associated LRRK2-G2019S mutation

    T. Courtin, G. Ianello, H. Bertrand, S. Benromdhan, C. Tesson, C. Mhiri, JC. Corvol, S. Lesage, A. Brice (Paris, France)

    Objective: The aim of the study is to use genome-wide approach to elucidate genetic variability that influences LRRK2 G2019S penetrance in Parkinson's Disease (PD). Background:…
  • 2019 International Congress

    Hereditary and geneological aspects of Parkinson’s disease and essential tremor in people of Uzbek nationality

    R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study the genealogic features of Parkinson’s disease and essential tremor in people of Uzbek nationality. Background: Parkinson's disease (PD)  and essential tremor (ET)…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177
  • 178
  • 179
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley